Dutch GPs’ views on prescribing mifepristone and misoprostol: a mixed-methods study

The British journal of general practice: the journal of the Royal College of General Practitioners

article

Julia EAP Schellekens¹  Claire SE Houtvast²  Peter Leusink³  Gunilla Kleiverda⁴  Rebecca Gomperts⁵ 

[1] University of Amsterdam;University of Groningen, University Medical Center Groningen;Utrecht.;Women on Waves;Women on Waves and Women on Web

关键词: abortion;    induced;    abortion;    missed;    general practitioners;    mifepristone;    misoprostol;    Netherlands;   

DOI  :  10.3399/BJGP.2021.0704

学科分类：卫生学

来源: Royal College of General Practitioners

【 摘 要 】

Background The World Health Organization has indicated that GPs can safely and effectively provide mifepristone and misoprostol for medical termination of pregnancy (TOP). Dutch GPs are allowed to treat miscarriages with mifepristone and misoprostol, but few do so. Current Dutch abortion law prohibits GPs from prescribing these medications for medical TOP. Medical TOP is limited to the specialised settings of abortion clinics and hospitals. Recently, the House of Representatives debated shifting abortion to the domain of primary care, following the example of France and the Republic of Ireland. This would improve access to sexual and reproductive health care, and increase choices for women. Nevertheless, little is known about GPs’ willingness to provide medical TOP and miscarriage management.Aim To gain insight into Dutch GPs’ willingness to prescribe mifepristone and misoprostol for medical TOP and miscarriages, as well as the anticipated barriers.Design and setting Mixed-methods study among Dutch GPs.Method A questionnaire provided quantitative data that were analysed using descriptive methods. Thematic analyses were performed on qualitative data collected through in-depth interviews.Results The questionnaire was sent to 575 GPs; the response rate was 22.1% (n = 127). Of the responders, 84.3% (n = 107) were willing to prescribe mifepristone and misoprostol, with 58.3% (n = 74) willing to provide this medication for both medical TOP and miscarriage management. A total of 57.5% (n = 73) of participants indicated a need for training. The main barriers influencing participants’ willingness to provide medical TOP and miscarriage management were lack of experience, lack of knowledge, time constraints, and a restrictive abortion law.Conclusion Over 80.0% of responders were willing to prescribe mifepristone and misoprostol for medical TOP or miscarriages. Training, (online) education, and a revision of the abortion law are recommended.

【 授权许可】

Free